Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06308887
Status:
COMPLETED
Last Update Posted:
2024-03-13
First Post:
2024-03-05
Brief Title:
Comparison of Ultrasound-Guided Perimeniscal Steroid and 5 Dextrose Injections in Knee Osteoarthritis
Sponsor:
Kastamonu University
Organization:
Kastamonu University
Study Overview
Official Title:
Comparison of the Effectiveness of Ultrasound-Guided Perimeniscal Steroid and Dextrose Injections in Knee Osteoarthritis
Status:
COMPLETED
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Introduction The primary goal of treating knee osteoarthritis is to reduce pain and improve the patients quality of life Medial meniscal extrusion is a condition that is linked to pain and disability in knee osteoarthritis and can be identified through ultrasound For patients with medial meniscal extrusion perimeniscal corticosteroid injection has been shown to be a helpful addition to primary treatment for moderate to severe pain relief Dextrose prolotherapy has also been found to provide periarticular benefits for knee osteoarthritis This study aims to compare the effectiveness of ultrasound-guided perimeniscal corticosteroid and perimeniscal dextrose injections in patients with osteoarthritis medial knee pain and medial meniscal extrusion
Method Patients with medial knee pain and meniscal extrusion were randomly divided into two groups using the double-block randomization method Group 1 included 15 patients who were administered an ultrasound-guided perimeniscal steroid injection while Group 2 included 16 patients who were administered an ultrasound-guided perimeniscal dextrose injection The patients pain levels were evaluated using the Visual Analog Pain Scale VAS and the Western Ontario and McMaster Universities Osteoarthritis Index WOMAC before and one week one month and three months after the injection
Method Patients with medial knee pain and meniscal extrusion were randomly divided into two groups using the double-block randomization method Group 1 included 15 patients who were administered an ultrasound-guided perimeniscal steroid injection while Group 2 included 16 patients who were administered an ultrasound-guided perimeniscal dextrose injection The patients pain levels were evaluated using the Visual Analog Pain Scale VAS and the Western Ontario and McMaster Universities Osteoarthritis Index WOMAC before and one week one month and three months after the injection
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None